CVT Stock Overview
Engages in research, manufacturing, marketing, and distribution nature health products in Australia, New Zealand, Greater China, rest of Asia, North America, Europe, the Middle East, Africa, and internationally.
Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 3/6 |
Past Performance | 1/6 |
Financial Health | 5/6 |
Dividends | 3/6 |
Rewards
Risk Analysis
+ 1 more risk
Comvita Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | NZ$1.38 |
52 Week High | NZ$3.48 |
52 Week Low | NZ$1.35 |
Beta | 0.50 |
1 Month Change | -30.65% |
3 Month Change | -37.84% |
1 Year Change | -52.41% |
3 Year Change | -58.68% |
5 Year Change | -63.00% |
Change since IPO | -37.27% |
Recent News & Updates
Recent updates
Here's Why Comvita (NZSE:CVT) Is Weighed Down By Its Debt Load
Mar 21Comvita Limited's (NZSE:CVT) 26% Dip In Price Shows Sentiment Is Matching Earnings
Feb 05A Look At The Fair Value Of Comvita Limited (NZSE:CVT)
Nov 27These 4 Measures Indicate That Comvita (NZSE:CVT) Is Using Debt Reasonably Well
Mar 25We Think Comvita's (NZSE:CVT) Robust Earnings Are Conservative
Mar 04Is It Too Late To Consider Buying Comvita Limited (NZSE:CVT)?
Mar 03Have Insiders Been Buying Comvita Limited (NZSE:CVT) Shares This Year?
Jan 29How Much Did Comvita's(NZSE:CVT) Shareholders Earn From Share Price Movements Over The Last Three Years?
Dec 22Could The Comvita Limited (NZSE:CVT) Ownership Structure Tell Us Something Useful?
Nov 25Shareholder Returns
CVT | NZ Personal Products | NZ Market | |
---|---|---|---|
7D | -23.8% | -10.8% | 1.0% |
1Y | -52.4% | -31.5% | -4.7% |
Return vs Industry: CVT underperformed the NZ Personal Products industry which returned -31.5% over the past year.
Return vs Market: CVT underperformed the NZ Market which returned -4.7% over the past year.
Price Volatility
CVT volatility | |
---|---|
CVT Average Weekly Movement | 8.1% |
Personal Products Industry Average Movement | 5.3% |
Market Average Movement | 4.2% |
10% most volatile stocks in NZ Market | 8.5% |
10% least volatile stocks in NZ Market | 2.7% |
Stable Share Price: CVT's share price has been volatile over the past 3 months.
Volatility Over Time: CVT's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of NZ stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1974 | 600 | David Banfield | www.comvita.co.nz |
Comvita Limited, together with its subsidiaries, engages in research, manufacturing, marketing, and distribution nature health products in Australia, New Zealand, Greater China, rest of Asia, North America, Europe, the Middle East, Africa, and internationally. The company offers Manuka honey, propolis, olive leaf extract, medihoney, gourmet honey, and elixirs and lozenges, as well as oral care and kids health products. It also provides solutions for digestive health, skin health, heart and metabolic health, and immunity.
Comvita Limited Fundamentals Summary
CVT fundamental statistics | |
---|---|
Market cap | NZ$96.91m |
Earnings (TTM) | NZ$3.70m |
Revenue (TTM) | NZ$225.43m |
26.2x
P/E Ratio0.4x
P/S RatioIs CVT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
CVT income statement (TTM) | |
---|---|
Revenue | NZ$225.43m |
Cost of Revenue | NZ$96.87m |
Gross Profit | NZ$128.56m |
Other Expenses | NZ$124.85m |
Earnings | NZ$3.70m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | 0.053 |
Gross Margin | 57.03% |
Net Profit Margin | 1.64% |
Debt/Equity Ratio | 41.9% |
How did CVT perform over the long term?
See historical performance and comparison